|
KMID : 1231220160070020053
|
|
Journal of the Korean Society for Research on Nicotine and Tobacco
2016 Volume.7 No. 2 p.53 ~ p.60
|
|
|
Current Status of Smoking Cessation Program in Foreign Countries
|
|
Choi Eun-Young
Cho Hong-Jun
Lee Jung-Ah
Lee Jin-Yong
Jung Hye-Min
Ock Min-Su
Lee Hyun-Jung
Son Woo-Seung
Jo Min-Woo
|
|
|
Abstract
|
|
|
|
Smoking cessation treatment using drugs, such as bupropion and varenicline, is an effective approach for helping smokers to stop smoking. According to the Framework Convention on Tobacco Control, many countries have established smoking cessation treatment programs in order to support smokers both financially and non-financially. This article summarizes the current status of smoking cessation treatment program in selected countries and suggests future strategies in Korea. In the US, both social and private insurance companies have provided smoking cessation programs as preventive services without copayment, according to the Patient Protection and Affordable Care Act. The UK NHS provides pharmaceutical treatments and behavioural support for all tobacco users. In 2006, social insurance of Japan began to benefit drug treatments for smokers in outpatient clinics. Chinese Taipei also provides a clinic-based, smoking cessation service which includes both counseling and pharmaceutical treatment. In British Columbia, Canada, all smokers can join in the state's smoking cessation program which provides nicotine replacement therapy, bupropion or varenicline for 12 weeks once a year. Australia covers the benefit of nicotine patch, bupropion and varenicline for smoking cessation, according to the Pharmaceutical Benefit Scheme. Many developed countries have provided smoking cessation programs using bupropion and varenicline without a copayment. The National Health Insurance Service of Korea began to subsidize the counselling fee and drug cost of smoking cessation treatment in 2015. In order to develop and improve this smoking cessation program, the Korean government should benefit from the experience of other countries.
|
|
|
KEYWORD
|
|
|
Smoking cessation, Treatment, Insurance benefit, Current status
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|